Omni Array Biotechnology Llc
- View government funding actions
- Bethesda, MD 20817
- Phone: 240-454-6130
- Estimated Number of Employees: 0
- Estimated Annual Receipts: $0
- Business Start Date: 2012
- Contact Person: Kodumudi Venkateswaran
- Contact Phone: 240-614-7412
- Contact Email: drv@omniarraybt.com
- Business Structure:
- Partnership or Limited Liability Partnership
- Business Type:
- For Profit Organization
- Limited Liability f
- Industries Served: Research and Development in Biotechnology
- Product Areas: WORD PROCESSING/TYPING SERVICES, SUPPORT- ADMINISTRATIVE: WORD PROCESSING/TYPING, OTHER ADMINISTRATIVE SUPPORT SVCS, SUPPORT- ADMINISTRATIVE: OTHER
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $1,799,641 - Monday the 11th of March 2013
Office Of Procurement Operations
SCIENCE AND TECHNOLOGY ACQUISITION DIVISION
IGF::OT::IGF DIVISION: CHEMICAL&BIOLOGICAL PPA: CBRNE DEFENSE R&D PROGRAM: BIOAGENT THREAT ASSESSMENT PROJECT: RAPID BIODETECTION PERFORMER: TBD APPROPRIATION YEAR: FY12 (24 FUNDS) BUDGET AUTHORITY: THREE YEAR R&D FUNDS PROJECT MANAGER: DAVID HODGE, 202-254-5813 LEAD SUPPORT STAFF: JASON RAMAGE, 202-254-6799 ALC: 70-08-1513 TAS: 70240800 DESCRIPTION: THE PURPOSE OF THIS REQUISITION IS TO EARMARK $1,800,000.00 FOR THE DEVELOPMENT OF NOVEL RAPID ANTHRAX DIAGNOSTIC TEST WITH HIGH SPECIFICITY AND SENSITIVITY FOR THE RAPID BAIODETECTION PROGRAM WITHIN THE DEPARTMENT OF HOMELAND SECURITY SCIENCE AND TECHNOLOGY (S&T) CHEMICAL AND BIOLOGICAL DIVISION. THE TOTAL ESTIMATED FUNDS OF THIS CONTRACT ARE $2,000,000.00. TOTAL OBLIGATED FUNDS OF THIS CONTRACT ARE $1,800,000. THE PERIOD OF PERFORMANCE IS 24 MONTHS FROM THE DATE OF CONTRACT AWARD. THE DHS TECHNICAL POINT OF CONTACT IS AS FOLLOWS: DAVID HODGE DEPARTMENT OF HOMELAND SECURITY SCIENCE AND TECHNOLOGY DIRECTORATE WASHINGTON, DC 20528 PHONE: 202.254.5813 E-MAIL: DAVID.HODGE@HQ.DHS.GOV
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.